Author Archives: Sara Agee Le

August 19, 2020
In The News

[AiThority] Recently, a news report suggested that a team of AI scientists have made a belligerent effort to identify hundreds of new drugs as a potential COVID-19 therapy. COVID-19 is caused by the novel coronavirus, SAR COV-2, whose origins have been speculated to be a wet market in Wuhan in China. AI engineers and pharmaceutical companies are […]

Read Article
August 13, 2020
Press Release

Atomwise recognized for achievements in AI-driven drug discovery and creation of the AtomNet® platform, which has tackled — and succeeded in — finding small molecule hits for more undruggable targets than any other platform NEW YORK, August 13, 2020 — CB Insights today named Atomwise to its second annual Digital Health 150 ranking, which showcases […]

Read Article
August 11, 2020
FeaturedPress Release

New financing will enable Atomwise to further scale the largest artificial intelligence (AI)-driven drug discovery portfolio in history and expand $5 billion+ deal pipeline for small molecule drug discovery SAN FRANCISCO — August 11, 2020 — Atomwise, the company deciphering human disease via the largest AI-drug discovery portfolio, announced today that it has closed $123 […]

Read Article
August 6, 2020
In The News

Porcine Reproductive and Respiratory Syndrome (PRRS) virus is the most economically damaging virus for global pork production, responsible for approximately $600 million in annual losses for American pig farmers alone. 

Read Article
August 6, 2020
In The News

Small molecule found to block CD163 surface receptor, which PRRS virus needs to infect pig cells and cause disease.

Read Article
August 6, 2020
In The News

University of Connecticut (UConn) researchers have identified a compound that can successfully block the Porcine Reproductive and Respiratory Syndrome (PRRS) virus. 

Read Article